Alternative Bank Tackles Nigeria's Medicine Security Crisis

Alternative Bank is taking significant steps to tackle Nigeria's medicine security crisis by providing targeted financing for local pharmaceutical manufacturers. This initiative comes in response to the country's heavy reliance on imported drugs, which was highlighted during the COVID-19 pandemic.

Dr. Jekwu Ozoemen, a representative of Alternative Bank, emphasized the urgency of localizing pharmaceutical production to ensure Nigeria's medicine security and sovereignty. The bank plans to deploy a unique asset-backed risk-sharing financing model that aligns repayment schedules with the actual cash flow of businesses, rather than imposing rigid loan stipulations.

This approach aims to support the growth and sustainability of local pharmaceutical companies. The financing will include support for stock vendors, distributors, and supply chain financing, with the goal of reducing the sector's dependence on foreign exchange.

Additionally, the initiative is expected to stimulate job creation across the entire pharmaceutical value chain, fostering economic resilience in Nigeria.